Skip to content
Clinical Trial Events
ISPOR Europe 2026

Talk Access and Pricing track

Preparing Orphan Medicinal Products for JCA: Strengthening the Evidence Package

Mon, Nov 9, 2026 · 3:15–3:45 PM CET Theater 1, Hall X1-X4, Level -2, Austria Center Vienna

About this session

The introduction of Joint Clinical Assessments (JCAs) is reshaping European HTA by establishing a common framework for clinical evidence assessment, while appraisal and national pricing and reimbursement decisions remain the responsibility of individual Member States.

Speakers